Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 881Pancreatic Neoplasms 572Carcinoma, Hepatocellular 545Stomach Neoplasms 514Esophageal Neoplasms 312Rectal Neoplasms 284Colonic Neoplasms 255Breast Neoplasms 204Neoplasms 201Liver Neoplasms 187Carcinoma, Non-Small-Cell Lung 175Lung Neoplasms 174Cholangiocarcinoma 153Ovarian Neoplasms 142Neoplasm Metastasis 137Gastrointestinal Neoplasms 135Esophageal Squamous Cell Carcinoma 130Melanoma 103Prostatic Neoplasms 99Biliary Tract Neoplasms 96Endometrial Neoplasms 83Uterine Cervical Neoplasms 79Head and Neck Neoplasms 72Squamous Cell Carcinoma of Head and Neck 69Carcinoma, Renal Cell 57Sarcoma 55Adenocarcinoma Of Esophagus 54Urinary Bladder Neoplasms 53Anus Neoplasms 52Triple Negative Breast Neoplasms 48

Interventions

Gemcitabine 2Cisplatin 2durvalumab 1Simvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Advanced Biliary Tract Carcinoma × Gastrointestinal × Clear all
NCT07036380 2026-06-01

TACTIC

Centre Hospitalier Universitaire de Besancon

Phase 2 Recruiting
75 enrolled
Gastrointestinal

Advanced Biliary Tract Carcinoma

NCT07392541 2026-03-23

Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer

Tongji Hospital

Phase 1/2 Recruiting
29 enrolled
Gastrointestinal

Advanced Biliary Tract Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡